Hans Hull

Hans Hull has an estimated net worth of $6.74 Million. This is based on reported shares across multiple companies, which include PLIANT THERAPEUTICS, INC., and Avalanche Biotechnologies, Inc..

2015 was Hans Hull's most active year for acquiring shares with 7 total transactions. Hans Hull's most active month to acquire stocks was the month of December. 2015 was Hans Hull's most active year for disposing of shares, totalling 8 transactions. Hans Hull's most active month to dispose stocks was the month of July. 2023 saw Hans Hull paying a total of $58,029.28 for 195,325 shares, this is the most they've acquired in one year. In 2015 Hans Hull cashed out on 77,300 shares for a total of $1,291,205.17, their largest year based on trade value.